These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19464773)

  • 1. Antioxidants in the prevention of atherosclerosis: the importance of proper patient selection.
    Levy Y; Blum S; Levy AP
    Clin Nutr; 2009 Oct; 28(5):581-2. PubMed ID: 19464773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial.
    Milman U; Blum S; Shapira C; Aronson D; Miller-Lotan R; Anbinder Y; Alshiek J; Bennett L; Kostenko M; Landau M; Keidar S; Levy Y; Khemlin A; Radan A; Levy AP
    Arterioscler Thromb Vasc Biol; 2008 Feb; 28(2):341-7. PubMed ID: 18032779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of pharmacogenomics in the prevention of diabetic cardiovascular disease: mechanistic basis and clinical evidence for utilization of the haptoglobin genotype in determining benefit from antioxidant therapy.
    Levy AP
    Pharmacol Ther; 2006 Nov; 112(2):501-12. PubMed ID: 16854468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomics in prevention of diabetic cardiovascular disease: utilization of the haptoglobin genotype in determining benefit from vitamin E.
    Levy AP; Blum S
    Expert Rev Cardiovasc Ther; 2007 Nov; 5(6):1105-11. PubMed ID: 18035926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin E and cardiovascular disease: observational studies.
    Gaziano JM
    Ann N Y Acad Sci; 2004 Dec; 1031():280-91. PubMed ID: 15753154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a role for supplemented antioxidants in the prevention of atherosclerosis?
    Katsiki N; Manes C
    Clin Nutr; 2009 Feb; 28(1):3-9. PubMed ID: 19042058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomic effect of vitamin E on kidney structure and function in transgenic mice with the haptoglobin 2-2 genotype and diabetes mellitus.
    Nakhoul FM; Miller-Lotan R; Awad H; Asleh R; Jad K; Nakhoul N; Asaf R; Abu-Saleh N; Levy AP
    Am J Physiol Renal Physiol; 2009 Apr; 296(4):F830-8. PubMed ID: 19176700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress, antioxidant vitamins, and atherosclerosis. From basic research to clinical practice.
    Antoniades C; Tousoulis D; Tentolouris C; Toutouzas P; Stefanadis C
    Herz; 2003 Nov; 28(7):628-38. PubMed ID: 14689123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction Between the Haptoglobin Genotype and Vitamin E on Cardiovascular Disease in Diabetes.
    Hochberg I; Berinstein EM; Milman U; Shapira C; Levy AP
    Curr Diab Rep; 2017 Jun; 17(6):42. PubMed ID: 28451949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a role for antioxidant vitamins in the prevention of cardiovascular diseases? An update on epidemiological and clinical trials data.
    Lonn EM; Yusuf S
    Can J Cardiol; 1997 Oct; 13(10):957-65. PubMed ID: 9374952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of vitamins C and E on oxidative stress markers and endothelial function in patients with systemic lupus erythematosus: a double blind, placebo controlled pilot study.
    Tam LS; Li EK; Leung VY; Griffith JF; Benzie IF; Lim PL; Whitney B; Lee VW; Lee KK; Thomas GN; Tomlinson B
    J Rheumatol; 2005 Feb; 32(2):275-82. PubMed ID: 15693087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No evidence supports vitamin E indiscriminate supplementation.
    Dotan Y; Lichtenberg D; Pinchuk I
    Biofactors; 2009; 35(6):469-73. PubMed ID: 19866453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 'vitamin E regeneration system' (VERS) and an algorithm to justify antioxidant supplementation in diabetes--a hypothesis.
    Nwose EU; Jelinek HF; Richards RS; Kerr PG
    Med Hypotheses; 2008; 70(5):1002-8. PubMed ID: 17959321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin E modulation of cardiovascular disease.
    Meydani M
    Ann N Y Acad Sci; 2004 Dec; 1031():271-9. PubMed ID: 15753153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The protean role of haptoglobin and haptoglobin genotypes on vascular complications in diabetes mellitus.
    Dalan R; Liuh Ling G
    Eur J Prev Cardiol; 2018 Sep; 25(14):1502-1519. PubMed ID: 29799294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Women's Antioxidant Cardiovascular Study: design and baseline characteristics of participants.
    Bassuk SS; Albert CM; Cook NR; Zaharris E; MacFadyen JG; Danielson E; Van Denburgh M; Buring JE; Manson JE
    J Womens Health (Larchmt); 2004; 13(1):99-117. PubMed ID: 15006283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin E and thetreatment and prevention of diabetes: a case for a controlled clinical trial.
    Halliwell B
    Singapore Med J; 2002 Sep; 43(9):479-84. PubMed ID: 12568428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamins and cardiovascular disease.
    Honarbakhsh S; Schachter M
    Br J Nutr; 2009 Apr; 101(8):1113-31. PubMed ID: 18826726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of lycopene in cardiovascular disease.
    Riccioni G; Mancini B; Di Ilio E; Bucciarelli T; D'Orazio N
    Eur Rev Med Pharmacol Sci; 2008; 12(3):183-90. PubMed ID: 18700690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on vitamin supplements for the prevention of coronary disease and stroke.
    Pearce KA; Boosalis MG; Yeager B
    Am Fam Physician; 2000 Sep; 62(6):1359-66. PubMed ID: 11011864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.